Protalix BioTherapeutics
PLX
#8704
Rank
โ‚น16.44 B
Marketcap
โ‚น204.08
Share price
0.92%
Change (1 day)
-6.15%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2025 (TTM): โ‚น1.74

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is โ‚น1.86. In 2024 the company made an earnings per share (EPS) of โ‚น3.73 a decrease over its 2023 EPS that were of โ‚น11.18.

EPS history for Protalix BioTherapeutics from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น1.74-53.19%
2024โ‚น3.73-66.67%
2023โ‚น11.18-138.71%
2022-โ‚น28.89-50%
2021-โ‚น57.78181.82%
2020-โ‚น20.50-82.11%
2019-โ‚น114.62-31.67%
2018-โ‚น167.73-72.31%
2017-โ‚น605.71124.14%
2016-โ‚น270.24-147.54%
2015โ‚น568.43-290.63%
2014-โ‚น298.206.67%
2013-โ‚น279.56130.77%
2012-โ‚น121.14-69.77%
2011-โ‚น400.7019.44%
2010-โ‚น335.47-12.2%
2009-โ‚น382.0636.67%
2008-โ‚น279.56-37.5%
2007-โ‚น447.2950%
2006-โ‚น298.203.23%
2005-โ‚น288.88138.46%
2004-โ‚น121.14-74%
2003-โ‚น465.93-0%
2002-โ‚น465.93-50%
2001-โ‚น931.86233.33%
2000-โ‚น279.56-84.21%
1999-โ‚น1,771-24%
1998-โ‚น2,330-600%
1997โ‚น465.93-16.67%
1996โ‚น559.12

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น126.73 6,700.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น449.16 24,000.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
-โ‚น10.25-650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น115.55 6,100.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel